
Jennifer Sue Pitrak Mcdonald
Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1609, 3796, 3792, 1635, 1674 |
| Total Applications | 600 |
| Issued Applications | 220 |
| Pending Applications | 26 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7650913
[patent_doc_number] => 20110300182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'NUCLEIC ACID DRUG FOR TREATMENT OF ALLERGIC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/119080
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 7771
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300182.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119080
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119080 | NUCLEIC ACID DRUG FOR TREATMENT OF ALLERGIC DISEASE | Mar 11, 2009 | Abandoned |
Array
(
[id] => 5987359
[patent_doc_number] => 20110098339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'C2ORF18 AS TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/921766
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 36871
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921766 | C2ORF18 AS TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS | Mar 9, 2009 | Abandoned |
Array
(
[id] => 6202858
[patent_doc_number] => 20110065644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'COMPOSITIONS COMPRISING HUMAN PCSK9 AND APOLIPOPROTEIN B SIRNA AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/921376
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26583
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065644.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921376 | COMPOSITIONS COMPRISING HUMAN PCSK9 AND APOLIPOPROTEIN B SIRNA AND METHODS OF USE | Mar 8, 2009 | Abandoned |
Array
(
[id] => 6630073
[patent_doc_number] => 20100004314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'USE OF SIRNA TO ACHIEVE DOWN REGULATION OF AN ENDOGENOUS GENE IN COMBINATION WITH THE USE OF A SENSE CONSTRUCT TO ACHIEVE EXPRESSION OF A POLYNUCLEOTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/400742
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 21567
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004314.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400742
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400742 | Compositions comprising siRNA and plasmids | Mar 8, 2009 | Issued |
Array
(
[id] => 5954497
[patent_doc_number] => 20110034538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/919893
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 76
[patent_no_of_words] => 27847
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034538.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919893 | MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6150014
[patent_doc_number] => 20110021609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/919901
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21400
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021609.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919901
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919901 | MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof | Feb 26, 2009 | Abandoned |
Array
(
[id] => 13237425
[patent_doc_number] => 10131904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Modified RNAi polynucleotides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 12/867181
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 37
[patent_no_of_words] => 30305
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867181 | Modified RNAi polynucleotides and uses thereof | Feb 10, 2009 | Issued |
Array
(
[id] => 6202988
[patent_doc_number] => 20110065774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/865636
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26144
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065774.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865636
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865636 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF | Jan 29, 2009 | Abandoned |
Array
(
[id] => 6024343
[patent_doc_number] => 20110052669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'METHODS FOR MODULATING DE NOVO HEPATIC LIPOGENESIS BY MODULATING XBP-1 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/812811
[patent_app_country] => US
[patent_app_date] => 2009-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43379
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812811
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812811 | Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity | Jan 13, 2009 | Issued |
Array
(
[id] => 5954493
[patent_doc_number] => 20110034535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'POSITIVE CONTROLS FOR EXPRESSION MODULATING EXPERIMENTS'
[patent_app_type] => utility
[patent_app_number] => 12/809523
[patent_app_country] => US
[patent_app_date] => 2008-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7717
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034535.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809523 | Positive controls for expression modulating experiments | Dec 28, 2008 | Issued |
Array
(
[id] => 8063677
[patent_doc_number] => 20110245184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'TREATMENT OF SURGICAL ADHESIONS'
[patent_app_type] => utility
[patent_app_number] => 12/809989
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31311
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245184.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809989
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809989 | TREATMENT OF SURGICAL ADHESIONS | Dec 21, 2008 | Abandoned |
Array
(
[id] => 5929826
[patent_doc_number] => 20110039785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/808439
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21736
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808439 | POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6503418
[patent_doc_number] => 20100260718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'IRF-4 AS A TUMOR SUPPRESSOR AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/747303
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26029
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260718.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747303
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747303 | IRF-4 AS A TUMOR SUPPRESSOR AND USES THEREOF | Dec 9, 2008 | Abandoned |
Array
(
[id] => 5355012
[patent_doc_number] => 20090186356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'DEVICE AND SUBSTANCE FOR THE IMMOBILIZATION OF MESENCHYMAL STEM CELLS (MSCs)'
[patent_app_type] => utility
[patent_app_number] => 12/324698
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8289
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12324698
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/324698 | DEVICE AND SUBSTANCE FOR THE IMMOBILIZATION OF MESENCHYMAL STEM CELLS (MSCs) | Nov 25, 2008 | Abandoned |
Array
(
[id] => 9232839
[patent_doc_number] => 08598143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Sequence-specific inhibition of small RNA function'
[patent_app_type] => utility
[patent_app_number] => 12/273673
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 40
[patent_no_of_words] => 30744
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12273673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/273673 | Sequence-specific inhibition of small RNA function | Nov 18, 2008 | Issued |
Array
(
[id] => 6433216
[patent_doc_number] => 20100152280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'MODULATION OF SID-1 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/258077
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27211
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152280.pdf
[firstpage_image] =>[orig_patent_app_number] => 12258077
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/258077 | MODULATION OF SID-1 EXPRESSION | Oct 23, 2008 | Abandoned |
Array
(
[id] => 10876499
[patent_doc_number] => 08901288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'High throughput methods for functionally determining RNA interference efficiency'
[patent_app_type] => utility
[patent_app_number] => 12/739382
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 38
[patent_no_of_words] => 27660
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739382 | High throughput methods for functionally determining RNA interference efficiency | Oct 23, 2008 | Issued |
Array
(
[id] => 6500195
[patent_doc_number] => 20100286243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'MIG-7 AS A SPECIFIC ANTICANCER TARGET'
[patent_app_type] => utility
[patent_app_number] => 12/738964
[patent_app_country] => US
[patent_app_date] => 2008-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 37696
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286243.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738964 | MIG-7 AS A SPECIFIC ANTICANCER TARGET | Oct 21, 2008 | Abandoned |
Array
(
[id] => 6491723
[patent_doc_number] => 20100093561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Methods for producing high density patterned cell arrays for biological assays'
[patent_app_type] => utility
[patent_app_number] => 12/285629
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8384
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093561.pdf
[firstpage_image] =>[orig_patent_app_number] => 12285629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/285629 | Methods for producing high density patterned cell arrays for biological assays | Oct 8, 2008 | Abandoned |
Array
(
[id] => 6600474
[patent_doc_number] => 20100292304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'COMPOUNDS AND METHODS FOR IMPROVING CELLULAR UPTAKE OF OLIGOMERIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/681593
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9351
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681593
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681593 | Compounds and methods for improving cellular uptake of oligomeric compounds | Oct 5, 2008 | Issued |